1. Home
  2. BGI vs ADVB Comparison

BGI vs ADVB Comparison

Compare BGI & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birks Group Inc.

BGI

Birks Group Inc.

HOLD

Current Price

$0.38

Market Cap

7.4M

Sector

N/A

ML Signal

HOLD

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$7.74

Market Cap

8.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGI
ADVB
Founded
1879
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
8.6M
IPO Year
2002
2023

Fundamental Metrics

Financial Performance
Metric
BGI
ADVB
Price
$0.38
$7.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
458.0K
758.1K
Earning Date
12-05-2025
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
5.21
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.57
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$0.19
52 Week High
$1.57
$24.23

Technical Indicators

Market Signals
Indicator
BGI
ADVB
Relative Strength Index (RSI) 39.37 48.28
Support Level $0.23 $3.95
Resistance Level $0.52 $9.50
Average True Range (ATR) 0.07 1.18
MACD 0.00 -0.17
Stochastic Oscillator 45.33 49.81

Price Performance

Historical Comparison
BGI
ADVB

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: